General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 11.90
-0.30 (-2.46%)
Jan 22, 2026, 2:20 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 742.07 million as of January 22, 2026. Its market cap has decreased by -34.05% in one year.
Market Cap
742.07M
Enterprise Value
3.06B
Revenue
251.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.90
Market Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 742.07M, an increase of 126.95%. That is a compound annual growth rate of 3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 729.90M | -6.61% |
| Dec 31, 2025 | 781.60M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |